Qiagen stock enters results day with EQT's EUR46.50 cash offer
Published on 11/04/2026 at 11:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSTakeover and Results Set the Agenda
- Preliminary third-quarter sales reached USD548 million, with adjusted diluted EPS of USD0.65.
- QIAGEN suspended its full-year 2026 outlook while the transaction is pending.
- Closing is expected in mid-2027, subject to acceptance and regulatory conditions.
Qiagen stock entered Wednesday, November 4, with investors focused on two linked developments: the proposed EQT takeover and QIAGEN's full third-quarter release due later in the day. On October 21, the company announced preliminary quarterly figures and said it had suspended its full-year outlook while the transaction remains pending.
Qiagen stock traded at 45.02 euros on Lang & Schwarz at 11:15 CET on Wednesday, November 4, 2026; see the real-time quote of Qiagen stock.
EQT Offer Sets the Strategic Direction
QIAGEN and EQT Private Equity agreed on an all-cash public takeover offer for all outstanding shares at EUR46.50 per share, according to Alliance News. The report said the offer values Qiagen at EUR10.8 billion in enterprise value and represents a 40% premium to the unaffected closing price of EUR33.15 on July 8.
The deal is expected to close in mid-2027. Completion requires, among other conditions, acceptance from at least 50% of the outstanding share capital plus one share and customary regulatory clearances. The tender offer has not yet commenced, and the offer document must be approved before the acceptance period can begin.
Qiagen's management and supervisory boards support the transaction. The company has said private ownership would provide greater flexibility for long-term investment, while shareholders would receive an all-cash consideration. That framing makes execution, regulatory approval and the eventual acceptance level the main variables for holders until closing.
Preliminary Results Point to Continued Growth
In its investor-relations release, QIAGEN reported preliminary third-quarter net sales of USD548 million at both reported and constant exchange rates. Adjusted diluted earnings per share was USD0.65 on both bases. The figures were released for the quarter ended September 30.
The company plans to publish the complete third-quarter results at approximately 22:05 Frankfurt time on Wednesday, November 4, equivalent to 16:05 in New York. QIAGEN will not hold an earnings conference call, limiting the immediate opportunity for investors to question management about the figures or the suspended outlook.
The combination of a pending cash offer and suspended guidance shifts the near-term focus away from a conventional standalone valuation debate. Investors are instead weighing the certainty of the proposed consideration against the timetable, conditions and risks that could affect completion.
The Dutch market backdrop can be followed in the current AEX market coverage.
More company developments are available in More news and analyses on Qiagen stock.
Qiagen N.V. Key Facts
- Company: Qiagen N.V.
- ISIN: NL0015002SN0
- Frankfurt ticker: QIA
- Lang & Schwarz quote: 45.02 euros at 11:15 CET on Wednesday, November 4, 2026
- Third-quarter preliminary sales: USD548 million
- Adjusted diluted EPS: USD0.65
- Proposed EQT offer: EUR46.50 per share
